EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Titel:
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Auteur:
Merchant, Akil A. Jorapur, Aparna McManus, Amy Liu, Ren Krasnoperov, Valery Chaudhry, Parvesh Singh, Mohan Harton, Lisa Agajanian, Mary Kim, Miriam Triche Jr, Timothy J. Druker, Brian J. Tyner, Jeffrey W. Gill, Parkash S.